Medicenna Therapeutics Corp is seeing a notable rise in its stock price, reflecting positive investor sentiment.
Medicenna Therapeutics Corp (MDNA.TO) is up by 4.60% today, closing at CA$0.46. This increase comes alongside recent corporate developments that likely boosted investor confidence.
Investor takeaway: For investors, today’s price movement may indicate growing optimism around Medicenna’s strategic initiatives and potential future growth.
Advertisement
Medicenna Therapeutics Corp
MDNA.TO
MDNA.TO
Medicenna Therapeutics Corp
WealthAwesomeMarket cap
$40.15M
52W high
$1.97
52W low
$0.34
1W change
+6.10%
Beta
2.10
Analyst Price Targets
Based on analyst covering MDNA · as of Sep 17, 2026
Wall Street analysts forecast MDNA stock price to rise 635.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+635.6% Upside
Current Price
C$0.43
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
46.6%
Annualized
90-Day Vol
50.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.52
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.46 | C$0.39 – C$0.54 |
| 60 trading days | C$0.49 | C$0.39 – C$0.62 |
| 90 trading days | C$0.52 | C$0.39 – C$0.69 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Medicenna's stock up 4.60% today
The stock's rise brings its market cap to CA$40.15 million, suggesting that while the company is gaining traction, it’s still in the early stages of its growth journey.
Bull case
The recent approval of all director nominees at the annual meeting shows strong governance and strategic direction, which can help build investor confidence.
Bear case
Despite today’s gains, Medicenna’s market cap remains relatively low at CA$40.15 million, raising concerns about its long-term sustainability and growth prospects.
Advertisement
Recent Corporate Developments
Medicenna recently announced the results of its annual general and special meeting of shareholders, where all director nominees were elected with over 97% approval. This strong backing from shareholders suggests a solid strategic direction for the company.
Market Sentiment and Future Outlook
With the stock rising today, investor sentiment seems to be shifting positively. The upcoming presentation at the H.C. Wainwright 28th Annual Global Investment Conference may further enhance visibility and interest in Medicenna’s innovative therapies. Investors should watch how these events unfold and their potential impact on the stock.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
